Insider Transactions in Q3 2022 at Axonics, Inc. (AXNX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
656
-8.04%
|
$49,200
$75.6 P/Share
|
|
Sep 12
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
32,483
-50.69%
|
$2,533,674
$78.16 P/Share
|
|
Sep 12
2022
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,483
+22.44%
|
$649,660
$20.01 P/Share
|
|
Sep 08
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.54%
|
$562,500
$75.01 P/Share
|
|
Sep 08
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.01%
|
$7,500
$1.53 P/Share
|
|
Sep 07
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,454
-24.86%
|
$742,234
$71.53 P/Share
|
|
Aug 25
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.09%
|
$547,500
$73.13 P/Share
|
|
Aug 18
2022
|
Esteban Lopez |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+27.27%
|
-
|
|
Aug 18
2022
|
David M Demski |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+24.3%
|
-
|
|
Aug 18
2022
|
Jane E Kiernan |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+11.08%
|
-
|
|
Aug 18
2022
|
Nancy Lynn Md Snyderman |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+11.03%
|
-
|
|
Aug 18
2022
|
Robert Mc Namara |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+15.04%
|
-
|
|
Aug 18
2022
|
Michael H Carrel |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+12.03%
|
-
|
|
Aug 11
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-47.97%
|
$3,550,000
$71.26 P/Share
|
|
Aug 11
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,502
+13.52%
|
$300,016
$8.86 P/Share
|
|
Aug 10
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
15,000
-11.61%
|
$1,035,000
$69.78 P/Share
|
|
Aug 10
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.87%
|
$7,500
$1.63 P/Share
|
|
Aug 10
2022
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,850
-21.15%
|
$2,335,650
$69.74 P/Share
|
|
Aug 10
2022
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,850
+12.55%
|
$609,300
$18.07 P/Share
|
|
Aug 08
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,000
-6.19%
|
$3,080,000
$70.91 P/Share
|
|
Aug 05
2022
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,094
-9.73%
|
$929,674
$71.13 P/Share
|
|
Jul 05
2022
|
Jane E Kiernan |
SELL
Open market or private sale
|
Direct |
5,250
-26.24%
|
$315,000
$60.0 P/Share
|